OCX OncoCyte Inc: שווי הפעילות העסקית

OncoCyte Corporation (OCX) is building a comprehensive precision analysis system, integrating genetic research into a full therapy cycle for oncology centers. The firm's operations are strictly regulated by FDA standards, including biomaterial disposal rules. The market valuation trend, which currently stands at , demonstrates growth potential in the liquid biopsy and early neoplasm detection segment.

Selecting stocks with a high margin of safety requires an analysis of the enterprise value, which sums the market capitalization and net debt to determine the total buyout price of the company. For OncoCyte Corporation (OCX), whose assets are based on ethical molecular diagnostics and highly skilled bioinformaticians, the real enterprise value on this chart reflects an objective market valuation of these intellectual and technological resources.